Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ariad Pharmaceuticals
Ariad Pharmaceuticals
Hedge Funds Are Buying These 10 High-Growth Biotech Stocks
Seeking Alpha
Sun, 07/15/12 - 11:30 am
Xoma
Jazz Pharmaceuticals
Pacific Biosciences
Amylin
Corcept Therapeutics
Santarus
Affymetrix
Ariad Pharmaceuticals
Amyris
Sequenom
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sun, 07/15/12 - 11:22 am
Alkermes
Medivation
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Questcor Pharmaceuticals
Arena Pharmaceuticals
Seattle Genetics
Incyte
United Therapeutics
Amarin
ONYX Pharmaceuticals
Pharmacyclics
Human Genome Sciences
Theravance
7 Healthcare Stocks Near Highs Being Bought Up By Hedge Funds
Seeking Alpha
Sat, 06/16/12 - 12:46 pm
Ardea Biosciences
Synta Pharmaceuticals
Akorn
Omeros
Santarus
Amylin
Ariad Pharmaceuticals
2 Positive Signs for Ariad
Motley Fool
Tue, 06/12/12 - 01:13 pm
Ariad Pharmaceuticals
US FDA rejects Merck/Ariad sarcoma drug
Reuters
Wed, 06/6/12 - 10:53 am
FDA
Merck
Ariad Pharmaceuticals
sarcoma
Taltorvic
4 Speculative Biotech Trades In The Economic Downturn
Seeking Alpha
Mon, 06/4/12 - 11:49 am
Merck
GSK
XenoPort
Taltorvic
soft tissue sarcomas
Ariad Pharmaceuticals
Horizant
postherpetic neuralgia
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1
Seeking Alpha
Thu, 05/24/12 - 12:53 pm
ASCO
Eli Lilly
Galena Biopharma
Dendreon
Exelixis
CytRx
Array Biopharma
Ariad Pharmaceuticals
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com
Thu, 05/17/12 - 10:35 am
ASCO
Array Biopharma
Exelixis
Pharmacyclics
Onyx
Seattle Genetics
Aveo
Ariad Pharmaceuticals
Arqule
Oncothyreon
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Pfizer, Johnson & Johnson, Ariad, and Medivation in Spotlight at Cancer Meeting
Minyanville
Wed, 05/16/12 - 10:53 am
ASCO
Pfizer
JNJ
Ariad Pharmaceuticals
Medivation
Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade
Seeking Alpha
Tue, 05/15/12 - 12:12 pm
ASCO
Allos
Ariad Pharmaceuticals
Arena Pharmaceuticals
Repligen
Sunesis
An ASCO Bio-Pharma Catalyst Trade With A Promising Leukemia Drug
Seeking Alpha
Wed, 05/9/12 - 10:19 am
leukemia
ASCO
Sunesis
Bristol-Myers Squibb
vosaroxin
Ariad Pharmaceuticals
Sanofi
AML
Novartis
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Upcoming ASCO Meeting Could Move These Stocks
Seeking Alpha
Wed, 04/4/12 - 08:45 am
ASCO
Allos
Ariad Pharmaceuticals
Arqule
Array Biopharma
ImmunoCellular Therapeutics
Exelixis
Are Ariad's Options Dwindling?
Motley Fool
Sun, 04/1/12 - 12:35 pm
Ariad Pharmaceuticals
ridaforolimus
Merck
GSK
Votrient
20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sun, 03/25/12 - 11:38 am
Achillion
Amylin
Ariad Pharmaceuticals
Aveo Pharmaceutical
Cell Therapeutics
EXACT Sciences
Idenix
Exelixis
Halozyme
Lexicon Pharmaceuticals
Nektar
Momenta
ONYX Pharmaceuticals
Optimer Pharmaceuticals
PDL Biopharma
Questcor Pharmaceuticals
Santarus
Spectrum Pharmaceuticals
Regeneron
Vivus
Cancer Cures: ASCO Stocks to Give Your Portfolio a Boost
Motley Fool
Sat, 03/24/12 - 11:30 am
Celldex
Arqule
JNJ
Ariad Pharmaceuticals
Aveo Pharmaceutical
4 Biopharma Swing Trades For The Mid Term - 3 Week Report Card
Seeking Alpha
Fri, 03/23/12 - 12:20 pm
Ariad Pharmaceuticals
Sanofi
Spectrum Pharmaceuticals
Questcor
Antares
Advisory Panel Pans Drug, Investors Shrug?
Motley Fool
Thu, 03/22/12 - 11:09 am
FDA
advisory panels
investors
ridaforolimus
Ariad Pharmaceuticals
Merck
FDA panel does not recommend Taltorvic
Reuters
Wed, 03/21/12 - 10:03 am
soft tissue sarcomas
FDA
advisory panels
Taltorvic
Merck
Ariad Pharmaceuticals
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »